Search

Abstract The closure of an ancient ocean basin via oceanic arc‐continent collision has two subduction styles with opposite polarities, which may proceed via subduction polarity reversal (SPR) or a subduction zone jump (SZJ). Interpreting the geometry or kinematic evolution of ancient collisional zones, especially the original subduction polarity, can be challenging. Here we used 2D thermo‐mechanical modeling to investigate the dynamic evolution process of SPR versus SZJ. Our modeling predicts different structural, topographic, magmatic, and basin histories for SPR and SZJ, which can be compared against, and help interpret, the geologic record past sites of oceanic closure during collisional orogens. Our results match geologic observations of past collisions in Kamchatka, eastern Russia, and the Banda Arc, eastern Indonesia, and thus our results can help effectively decode the evolutionary history of past arc‐continent collisions.

Esophageal squamous cell carcinoma (ESCC) is an aggressive and fatal disease that is usually diagnosed when the chances for surgical intervention has been missed. Definitive concurrent chemoradiotherapy (dCRT) is the first choice of treatment for inoperable locally advanced esophageal squamous cell carcinoma (LA-ESCC). Nevertheless, the local recurrence rate for esophageal cancer patients undergoing dCRT remains high at 40-60%, with a 5-year overall survival rate of solely 10-30%. Immunotherapy in combination with dCRT is a promising treatment for inoperable LA-ESCC, for that improved long-term survival is expected. The present review provides a comprehensive overview of the evolutionary trajectory of dCRT for LA-ESCC, delineates notable relevant clinical studies, addresses unresolved concerns regarding the combination of dCRT with immunotherapy, and highlights promising directions for future research. When dCRT is combined with immunotherapy, the following aspects should be carefully explored in the future studies, including the optimal irradiation dose, segmentation scheme, radiotherapy technique, timing, sequence and duration of radiotherapy, and the selection of chemotherapeutic and immunologic drugs. In addition, further investigations on the mechanisms of how dCRT combined with immunotherapy exerts synergistic anti-tumor effects and molecular biomarkers ensuring precise screening of ESCC patients are needed.

Background: Pelareorep is an oncolytic virus that causes oncolytic effects in many solid tumors, and it has shown therapeutic benefits. However, few studies have compared pelareorep combined with chemotherapy to traditional chemotherapy alone in advanced solid tumors. Consequently, we intended to evaluate the effectiveness and safety of pelareorep plus chemotherapy in this paper.Methods: We searched four databases including PubMed, Embase, Cochrane Library and Web of Science comprehensively for studies comparing pelareorep combined with chemotherapy to chemotherapy alone in the treatment of advanced solid tumors. The outcomes measures were 1-year overall survival (OS), 2-year OS, 4-month progression-free survival (PFS), 1-year PFS, objective response rate (ORR), any-grade adverse events (any-grade AEs), and severe AEs (grade ≥ 3).Results: There were five studies involving 492 patients included in the study. Combination therapy did not significantly improve clinical outcomes in terms of 1-year OS [RR = 1.02, 95%CI = (0.82–1.25)], 2-year OS [RR = 1.00, 95%CI = (0.67–1.49)], 4-month PFS [RR = 1.00, 95%CI = (0.67–1.49)], 1-year PFS [RR = 0.79, 95%CI = (0.44–1.42)], and ORR [OR = 0.79, 95%CI = (0.49–1.27)] compared to chemotherapy alone, and the subgroup analysis of 2-year OS, 1-year PFS, and ORR based on countries and tumor sites showed similar results. In all grades, the incidence of AEs was greater with combination therapy, including fever [RR = 3.10, 95%CI = (1.48–6.52)], nausea [RR = 1.19, 95%CI = (1.02–1.38)], diarrhea [RR = 1.87, 95%CI = (1.39–2.52)], chills [RR = 4.14, 95%CI = (2.30–7.43)], headache [RR = 1.46, 95%CI = (1.02–2.09)], vomiting [RR = 1.38, 95%CI = (1.06–1.80)] and flu-like symptoms [RR = 4.18, 95%CI = (2.19–7.98)]. However, severe adverse events did not differ significantly between the two arms.Conclusion: Pelareorep addition to traditional chemotherapy did not lead to significant improvements in OS, PFS, or ORR in advanced solid tumor patients, but it did partially increase AEs in all grades, with no discernible differences in serious AEs. Therefore, the combination treatment is not recommended in patients with advanced solid tumors.Systematic Review Registration:https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=400841, identifier CRD42023400841

Continents are formed by the amalgamation of numerous micro-terranes and island arcs, so they have spatially varying lithosphere strengths. The Crème br?lée (CB) model and the Jelly sandwich (JS) model have been commonly used to describe continental lithosphere strength-depth variations. Depending on the strength of continental lower crust, the CB and JS models can be further subdivided into two subclasses, in which the I subclass (CB-I and JS-I) and II subclass (CB-II and JS-II) respectively have a strong or weak lower crust. During continental collision, lithosphere deformation is the byproduct of the comprehensive interaction of multiple terranes. Here we used 2-D thermo-mechanical numerical models that contain three continental terranes to systematically explore the effects of terranes with various strengths on continental deformation, and studied the effects of different rheological assumptions terrane deformation. We find four types of lithosphere deformation patterns: collision, subduction, thickening and delamination, and replacement. Lithosphere structures, especially local pre-existing weaknesses, also have nonnegligible influences on lithosphere deformation. These simulation patterns are seen in observed deformation patterns and structures in East Asia, suggesting they are likely to be naturally occurring modes of intracontinental orogenesis. [ABSTRACT FROM AUTHOR]